Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metastatic Breast Cancer

Links shared publicly online about this topic.

  • 301
    total visits

Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metastatic Breast Cancer

medicalnewstoday.com —

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre L©on B©rard (Lyon), the major cancer research and t

View full resource at medicalnewstoday.com

Tags: Cancer Medication, Breast Cancer, Metastatic Breast Cancer, Colorectal Cancer Medication, Clinical Trial, Women's Health, Xeloda

  • Share

Most Recently Shared on May 11, 2011 at 4:05 pm By:

mnt_cancer MNT Cancer News

Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metas... http://mnt.to/3VJb

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Breast Cancer MNT Breast Cancer

MNT Clinical Trials MNT Clinical Trials

Advertisement